These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7042769)

  • 21. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study.
    Robert R; Blakeney PE; Villarreal C; Rosenberg L; Meyer WJ
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):873-82. PubMed ID: 10405506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of responders to fluoxetine.
    Reimherr FW; Wood DR; Byerley B; Brainard J; Grosser BI
    Psychopharmacol Bull; 1984; 20(1):70-2. PubMed ID: 6371874
    [No Abstract]   [Full Text] [Related]  

  • 23. S-adenosylmethionine in depression. A literature review and preliminary report.
    Janicak PG; Lipinski J; Davis JM; Comaty JE; Waternaux C; Cohen B; Altman E; Sharma RP
    Ala J Med Sci; 1988 Jul; 25(3):306-13. PubMed ID: 3052139
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings].
    Stewart JW; Quitkin F; Liebowitz MR; McGrath PJ; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):136-8. PubMed ID: 7015394
    [No Abstract]   [Full Text] [Related]  

  • 27. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine versus imipramine.
    Loeb C; Albano C; Gandolfo C
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():75-9. PubMed ID: 2783703
    [No Abstract]   [Full Text] [Related]  

  • 29. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D; Lapierre YD; Weinstein R; Klein J; Wiens A; Jones B; Horn E; Browne M; Bourget D; Blanchard A
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
    Stewart JW; Mercier MA; Agosti V; Guardino M; Quitkin FM
    J Clin Psychopharmacol; 1993 Apr; 13(2):114-9. PubMed ID: 8463443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo.
    Preskorn SH; Weller EB; Hughes CW; Weller RA; Bolte K
    Psychopharmacol Bull; 1987; 23(1):128-33. PubMed ID: 3602308
    [No Abstract]   [Full Text] [Related]  

  • 34. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 35. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD
    Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
    Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
    J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipramine treatment of prepubertal major depressive disorders: plasma levels and clinical response--preliminary report.
    Puig-Antich JP; Perel JM; Chambers WJ
    Psychopharmacol Bull; 1980 Jan; 16(1):25-7. PubMed ID: 6987693
    [No Abstract]   [Full Text] [Related]  

  • 40. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.